“Weighted blankets can reduce restlessness, soften racing thoughts, and reduce physical symptoms associated with anxiety, ...
Explore innovative ADHD therapies that focus on reducing neural noise to improve attention and focus in individuals.
Your home environment can have a significant impact on your mental health, especially during the colder months. Here’s how ...
Interesting Engineering on MSN
7 advances in medicine from 2025 that offered new hope for severe diseases
Scientists and clinicians reported advances that addressed conditions once thought irreversible, from congenital deafness and ...
Vanda Pharmaceuticals received FDA approval for Nereus for motion sickness, and its shares offer upside potential into 2026 ...
If you're constantly snacking, always ordering takeout or these other signs, it could point to something bigger.
Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...
The FDA has approved tradipitant (Nereus), an oral NK-1 receptor antagonist, for preventing motion-induced vomiting in adults ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has ...
US FDA approves Vanda Pharma’s Nereus, an oral NK-1 receptor antagonist for prevention of vomiting induced by motion: Washington Friday, January 2, 2026, 15:00 Hrs [IST] Vanda P ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial stage biotechnology company, today announced it has entered into a securities purchase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback